Anderson Compounding Pharmacy Recalls Prostaglandin Vials Due to Sterility Concerns
Anderson Compounding Pharmacy is recalling 23 vials of Prostaglandin 20 mcg/mL due to a lack of sterility assurance. The product was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard such as lack of sterility assurance in a drug product warrants a score of 4 (Severe), as it poses a risk of serious adverse health consequences.
Plain-English summary
Anderson Compounding Pharmacy, Inc. is recalling 23 vials of Prostaglandin 20 mcg/mL, 10 mL Vial. The recall was initiated because of a lack of sterility assurance in the product.
The affected product was distributed nationwide. The recall covers all lots of the medication.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication.
The recalled product
- Product
- Prostaglandin 20 mcg/mL, 10 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
- Category
- Drug — Compounded Medication
- Hazard
- Affected units
- 23
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 68 recalled by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 68 products in this recall →Related recalls
Same manufacturer · Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
See all →- HighAnderson Compounding Pharmacy Recalls Prostaglandin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereProstaglandin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
- SevereEstrone Oil Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
- SevereAnderson Compounding Pharmacy Recalls HCG Vials Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereGentamicin Irrigation Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereThe Apothecary Recalls Prostaglandin and Other Medications Due to Sterility Concerns
FDA (Drugs) · 2016-09-28
- HighProstaglandin Injectable Recalled Nationwide Due to Sterility Assurance Concerns
FDA (Drugs) · 2023-01-18
- HighFDA Recalls Prostaglandin E1 Injection for Lack of Sterility Assurance
FDA (Drugs) · 2023-01-18
- HighProstaglandin E1 Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2022-11-09
- SevereUS Compounding Recalls Methylprednisolone/Lidocaine Vials Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereProgesterone Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23